Research Article

Type 2 Diabetes in Young Females Results in Increased Serum Amyloid A and Changes to Features of High Density Lipoproteins in Both HDL2 and HDL3

Table 1

Subject characteristics.

Control group
()
T2DM group
()

Age (years)37.26 (11.77)37.05 (4.98)0.914
BMI (kg/m2)33.52 (7.93)35.88 (7.72)0.171
Fasting glucose (mmol/L)4.94 (4.60, 5.13)7.78 (6.10, 9.35)<0.001
HbA1c (%)5.42 (5.13, 5.60)7.26 (6.10, 8.05)<0.001
Total cholesterol (mmol/L)4.69 (0.92)4.50 (0.95)0.363
Triglycerides (mmol/L)1.24 (0.87, 1.70)1.53 (1.03, 2.10)0.074
LDL cholesterol (mmol/L)2.80 (0.77)2.74 (0.76)0.730
HDL cholesterol (mmol/L)1.20 (1.08, 1.34)1.03 (0.89, 1.14)0.004
Metformin (number)026NA
Sulfonylurea (number)07NA
DDP-4 inhibitor (number)04NA
GLP1 analogue (number)08NA
Insulin (number)05NA

Results expressed as mean (SD) or as geometric mean (interquartile range) if not normally distributed, where indicates skewed distributions.